193 related articles for article (PubMed ID: 30455641)
1. N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway.
Mohan CD; Bharathkumar H; Dukanya ; Rangappa S; Shanmugam MK; Chinnathambi A; Alharbi SA; Alahmadi TA; Bhattacharjee A; Lobie PE; Deivasigamani A; Hui KM; Sethi G; Basappa ; Rangappa KS; Kumar AP
Front Pharmacol; 2018; 9():1125. PubMed ID: 30455641
[TBL] [Abstract][Full Text] [Related]
2. Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells.
Mohan CD; Anilkumar NC; Rangappa S; Shanmugam MK; Mishra S; Chinnathambi A; Alharbi SA; Bhattacharjee A; Sethi G; Kumar AP; Basappa ; Rangappa KS
Front Oncol; 2018; 8():42. PubMed ID: 29616186
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells.
Somu C; Mohan CD; Ambekar S; Dukanya ; Rangappa S; Baburajeev CP; Sukhorukov A; Mishra S; Shanmugam MK; Chinnathambi A; Awad Alahmadi T; Alharbi SA; Basappa ; Rangappa KS
Biotechnol Rep (Amst); 2020 Mar; 25():e00438. PubMed ID: 32140443
[TBL] [Abstract][Full Text] [Related]
4. Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma.
Neelgundmath M; Dinesh KR; Mohan CD; Li F; Dai X; Siveen KS; Paricharak S; Mason DJ; Fuchs JE; Sethi G; Bender A; Rangappa KS; Kotresh O; Basappa
Bioorg Med Chem Lett; 2015 Feb; 25(4):893-7. PubMed ID: 25592709
[TBL] [Abstract][Full Text] [Related]
5. Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
Nirvanappa AC; Mohan CD; Rangappa S; Ananda H; Sukhorukov AY; Shanmugam MK; Sundaram MS; Nayaka SC; Girish KS; Chinnathambi A; Zayed ME; Alharbi SA; Sethi G; Basappa ; Rangappa KS
PLoS One; 2016; 11(9):e0163209. PubMed ID: 27685808
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
7. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
Zhang M; Zhang H; Cheng S; Zhang D; Xu Y; Bai X; Xia S; Zhang L; Ma J; Du M; Wang Y; Wang J; Chen M; Leng J
Tumour Biol; 2014 Jul; 35(7):7135-45. PubMed ID: 24760275
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-κB.
Xue Y; Chen C; Xu W; Xu H; Zheng J; Gu Y
Oncol Lett; 2018 May; 15(5):7693-7701. PubMed ID: 29731900
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
11. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
[TBL] [Abstract][Full Text] [Related]
13. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway.
Shen ZT; Chen Y; Huang GC; Zhu XX; Wang R; Chen LB
BMC Cancer; 2019 Nov; 19(1):1075. PubMed ID: 31703572
[TBL] [Abstract][Full Text] [Related]
14. Osthole attenuates angiogenesis in an orthotopic mouse model of hepatocellular carcinoma via the downregulation of nuclear factor-κB and vascular endothelial growth factor.
Yao F; Zhang L; Jiang G; Liu M; Liang G; Yuan Q
Oncol Lett; 2018 Oct; 16(4):4471-4479. PubMed ID: 30214582
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
[TBL] [Abstract][Full Text] [Related]
18. Moscatilin Inhibits Metastatic Behavior of Human Hepatocellular Carcinoma Cells: A Crucial Role of uPA Suppression via Akt/NF-κB-Dependent Pathway.
Yu CL; Weng MS; Chen WC; Chien KT; Chi CW; Chung CH; Huang CW; Wang PC; Chen CC; Tsai AC; Liu SC; Wang SW
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805784
[TBL] [Abstract][Full Text] [Related]
19. PMS1077 sensitizes TNF-α induced apoptosis in human prostate cancer cells by blocking NF-κB signaling pathway.
Shi J; Chen J; Serradji N; Xu X; Zhou H; Ma Y; Sun Z; Jiang P; Du Y; Yang J; Dong C; Wang Q
PLoS One; 2013; 8(4):e61132. PubMed ID: 23593410
[TBL] [Abstract][Full Text] [Related]
20. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
